Alendronate sodium and Peripheral embolism - a phase IV clinical study of FDA data

Summary:

Peripheral embolism is reported as a side effect among people who take Alendronate sodium (alendronate sodium), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Fosamax, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Peripheral embolism when taking Alendronate sodium. It is created by eHealthMe based on reports of 42,896 people who have side effects when taking Alendronate sodium from the FDA, and is updated regularly.

What is Alendronate sodium?

Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.

What is Peripheral embolism?

Peripheral embolism (sudden interruption of blood flow to an organ or body part) is found to be associated with 232 drugs and 351 conditions by eHealthMe. Check the latest studies of Peripheral embolism.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

42,896 people reported to have side effects when taking Alendronate sodium.
Among them, 15 people (0.03%) have Peripheral embolism.

Could Alendronate sodium cause Peripheral embolism?

Among these 15 people:

How long have people been on Alendronate sodium when they have Peripheral embolism? *

What is the gender of people who have Peripheral embolism when taking Alendronate sodium? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Peripheral embolism when taking Alendronate sodium? *

What are other drugs people take besides Alendronate sodium? *

Fosamax: 11 people, 73.33%
Boniva: 3 people, 20.00%
Actonel: 3 people, 20.00%
Aldactone: 2 people, 13.33%
Xarelto: 2 people, 13.33%
Calcium: 2 people, 13.33%
Lasix: 2 people, 13.33%
Amlodipine Besylate: 1 person, 6.67%
Aspirin: 1 person, 6.67%
Benazepril Hydrochloride: 1 person, 6.67%

What are other side effects people have besides Peripheral embolism? *

Femur Fracture: 8 people, 53.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 53.33%
Impaired Healing: 7 people, 46.67%
Joint Pain: 6 people, 40.00%
Broken Bone: 6 people, 40.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 33.33%
Oedema Peripheral (superficial swelling): 5 people, 33.33%
Chest Pain: 5 people, 33.33%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 4 people, 26.67%
Spinal Compression Fracture (fracture due to spinal compression on bone): 4 people, 26.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 20.00%
High Blood Pressure: 2 people, 13.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 13.33%
Type 2 Diabetes: 1 person, 6.67%
Pain: 1 person, 6.67%
Hypersensitivity: 1 person, 6.67%
Heart Rate Irregular: 1 person, 6.67%
Constipation: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Alendronate sodium and have Peripheral embolism?

- Check whether Peripheral embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alendronate sodium:

Alendronate sodium (43,608 reports)

Browse all side effects of Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral embolism:

Peripheral embolism (232 drugs)

Browse all the conditions that are associated with Peripheral embolism:

Peripheral embolism (351 conditions)

Related publications that referenced our studies

Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on alendronate sodium (the active ingredients of Alendronate sodium) and Alendronate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.